ASND — Ascendis Pharma A/S stock price, charts and financials

QT66Ascendis Pharma A/S

Ascendis Pharma A/S (NASDAQ: ASND) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
236.72
-2.32-0.97%
OverviewShort InterestFilings
ASNDQT66Ascendis Pharma A/S·NASDAQ
236.72-0.97%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 15, 20266-KForeign issuer report
Sep 15, 20266-KForeign issuer report
Sep 09, 20264Statement of changes in beneficial ownership
Sep 09, 20266-KForeign issuer report
Sep 09, 20266-KForeign issuer report
Sep 03, 20264Statement of changes in beneficial ownership
Aug 31, 20266-KForeign issuer report
Aug 18, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 20266-KForeign issuer report
Aug 13, 20266-KForeign issuer report
Aug 12, 20266-KForeign issuer report
Aug 06, 20266-KForeign issuer report
Jul 15, 20266-KForeign issuer report
Jun 30, 20266-KForeign issuer report
Jun 29, 20266-KForeign issuer report
Jun 17, 20266-KForeign issuer report
Jun 15, 20266-KForeign issuer report
Jun 12, 20266-KForeign issuer report
Jun 10, 20266-KForeign issuer report
Jun 02, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20263/AInitial statement of beneficial ownership (amended)
May 27, 20264Statement of changes in beneficial ownership
#1 / 25 of 329
Page
▼
/ 14